APOE and Alzheimer disease: Fourth, we test whether each of the three predictions are moderated (1) by a key AD genetic risk factor (stratified into APOE ε4− versus ε4+) and (2) further moderated by an AD-GRS (as stratified into low and high AD-GRS), to predict differential EF performance and decline in non-demented aging (see Figure 1).